{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:33:34Z","timestamp":1769574814756,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.nmd.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T15:45:38Z","timestamp":1479483938000},"page":"294-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intrafamilial phenotypic variability in Andersen\u2013Tawil syndrome: A diagnostic challenge in a potentially treatable condition"],"prefix":"10.1016","volume":"27","author":[{"given":"A.","family":"Ardissone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nmd.2016.11.006_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nurt.2007.01.005","article-title":"Management and treatment of Andersen-Tawil syndrome (ATS)","volume":"4","author":"Sansone","year":"2007","journal-title":"Neurother"},{"key":"10.1016\/j.nmd.2016.11.006_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410420306","article-title":"Andersen's syndrome: a distinct periodic paralysis","volume":"42","author":"Sansone","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2016.11.006_bib0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajmg.a.31092","article-title":"Andersen\u2013Tawil syndrome: prospective cohort analysis and expansion of the phenotype","volume":"140","author":"Yoon","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2016.11.006_bib0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2016.11.006_bib0030","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/01.WNL.0000072261.14060.47","article-title":"PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome","volume":"60","author":"Donaldson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.11.006_bib0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen\u2013Tawil syndrome patients with KCNJ2 mutations: characteristic T\u2013U wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2016.11.006_bib0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/humu.9483","article-title":"Genotype\u2013phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen\u2013Tawil syndrome","volume":"28","author":"Haruna","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2016.11.006_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/362127a0","article-title":"Primary structure and functional expression of a mouse inward rectifier potassium channel","volume":"362","author":"Kubo","year":"1993","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.nmd.2016.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0000000000000239","article-title":"A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1","volume":"82","author":"Kokunai","year":"2014","journal-title":"Neurology"},{"issue":"12):","key":"10.1016\/j.nmd.2016.11.006_bib0055","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1113\/JP271930","article-title":"Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2-associated Andersen-Tawil Syndrome","volume":"594","author":"Adams","year":"2016","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.nmd.2016.11.006_bib0060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/342360","article-title":"KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes","volume":"71","author":"Andelfinger","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2016.11.006_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2016.11.006_bib0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)81993-5","article-title":"Regions responsible for the assembly of inwardly rectifying potassium channels","volume":"87","author":"Tinker","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2016.11.006_bib0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0008-6363(03)00434-6","article-title":"Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion","volume":"59","author":"Lange","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.nmd.2016.11.006_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.59.3.466","article-title":"Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome","volume":"59","author":"Junker","year":"2002","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2016.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000178888.03767.74","article-title":"Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation","volume":"65","author":"Davies","year":"2005","journal-title":"Neurology"},{"issue":"3A","key":"10.1016\/j.nmd.2016.11.006_bib0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1590\/S0004-282X2006000400009","article-title":"Andersen syndrome: an association of periodic paralysis, cardiac arrhythmia and dysmorphic abnormalities","volume":"64","author":"Tengan","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"issue":"9","key":"10.1016\/j.nmd.2016.11.006_bib0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8167.2008.01216.x","article-title":"Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery","volume":"19","author":"Subbiah","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.nmd.2016.11.006_bib0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CND.0000000000000052","article-title":"Andersen-Tawil syndrome with early fixed myopathy","volume":"16","author":"Lefter","year":"2014","journal-title":"J Clin Neuromuscul Dis"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2016.11.006_bib0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jns.2014.09.040","article-title":"A case of Andersen-Tawil syndrome presenting periodic paralysis exacerbated by acetazolamide","volume":"347","author":"Nagamine","year":"2014","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.nmd.2016.11.006_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/mus.24293","article-title":"Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement","volume":"51","author":"Kostera-Pruszczyk","year":"2015","journal-title":"Muscle Nerve"},{"issue":"15","key":"10.1016\/j.nmd.2016.11.006_bib0115","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1212\/WNL.0000000000002430","article-title":"A newly approved drug for a rare group of diseases: dichlorphenamide for periodic paralysis","volume":"86","author":"Fontaine","year":"2016","journal-title":"Neurology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:06:02Z","timestamp":1760774762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616300906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0960896616300906"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.11.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrafamilial phenotypic variability in Andersen\u2013Tawil syndrome: A diagnostic challenge in a potentially treatable condition","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}